For Business Use Only. Does Not Ship to Residential Addresses. For use inside an Analyzer, Sold Separately.

Immunalysis 618UR-0100 SEFRIA Fentanyl Reagent, 100mL

https://www.myco-instrumentation.com/web/image/product.template/100397/image_1920?unique=62e76c5

Immunalysis 618UR-0100 SEFRIA Fentanyl Reagent, 100mL

In Stock

0.00 0.0 USD 0.00

0.00

This combination does not exist.

Get your quote in 90 minutes.
Trade in your older analyzers to recover budget.
Bundle equipment, reagents, & consumables into one cost-saving order.
Enlist our local service tech to keep uptime high.
Lower your cost per test.

Product Code: 618UR-0100

Manufacturer: Immunalysis Corporation

Shipping Weight: 2.00lbs (0.91kg)

WHY CHOOSE MYCO INSTRUMENTATION?
See Why in 2 mins.

Immunalysis 618UR-0100 SEFRIA Fentanyl Reagent, 100mL

SEFRIA™ reagents comprise the next generation immunoassay utilizing β-galactosidase enzyme allowing for lower cutoffs, wider assay span, and enhanced precision in a ready-to-use liquid format.

Our SEFRIA™ Fentanyl is the first-ever FDA 510(k) cleared assay designed for qualitative testing at a 1 ng/mL cutoff.

  • High sensitivity
  • Liquid stable and ready to use
  • Designed for use on chemistry analyzers

Fentanyl is a synthetic narcotic analgesic of high potency and short duration of action. The drug is available as a citrate salt in an injectable solution containing 50 μg/mL. It is also available as a transdermal patch containing 2.5–10 mg fentanyl and provides a dose of 25–100 μg/hr for 72 hours for management of chronic pain.2

While fentanyl has all the properties of morphine, it is structurally different and therefore cannot be detected by screening tests for morphine and related opiates.

Administration: Intravenous, transdermal patch, flavored lozenges, lollipop, buccal tablets, nasal spray, and inhalant.

The Immunalysis® Fentanyl Urine SEFRIA™ Drug Screening Kit detects the presence of fentanyl and its major metabolites in human urine samples with a cutoff of 1 ng/mL for qualitative testing. In clinical performance studies, testing with the Fentanyl Urine SEFRIA™ Drug Screening Kit compared favorably to liquid chromatography-mass spectrometry (LC-MS) analysis in both sensitivity (identification of positive results) and specificity (identification of negative results).